The present invention relates to processes, arrangements and systems which obtain information associated with an anatomical structure or a sample using optical microscopy, and more particularly to such methods, systems and arrangements that provide optical frequency domain imaging of the anatomical structure/sample (e.g., at least one portion of an eye).
Optical frequency domain imaging (“OFDI”), which may also be known as swept source optical coherence tomography (“OCT”), is a technique associated with OCT concepts that generally uses a wavelength-swept light source to probe the amplitude and phase of back scattering light from tissue. Exemplary OFDI techniques and systems are described in International Application No. PCT/US04/029148. Method and system to determine polarization properties of tissue is described in International Application No. PCT/US05/039374. The OFDI technique can offer intrinsic signal-to-noise ratio (“SNR”) advantage over the time-domain techniques because the interference signal can be effectively integrated through a Fourier transform. With the recently developed rapidly tunable lasers in the 1300-nm range, the OFDI technique has enabled significant improvements in, e.g., imaging speed, sensitivity, and ranging depth over the conventional time-domain OCT systems. For example, such OFDI procedures/techniques can be used for imaging skin, coronary artery, esophagus, and anterior eye segments.
While retinal imaging is an established clinical use of the OCT techniques, this application has not been implemented using the OFDI procedures because the optical absorption in the human eye at 1300 nm may be too large. The standard spectral range of the conventional ophthalmic OCT techniques has been between 800 nm and 900 nm where the humors in the eye are transparent and broadband super-luminescent-diode (“SLD”) light sources are readily available. It has been has suggested that the 1040-nm spectral range can be a viable alternative operating window for a retinal imaging, and can potentially offer a deeper penetration into the choroidal layers below the highly absorbing and scattering retinal pigment epithelium. The spectral domain (“SD”) OCT systems, also known as Fourier domain OCT systems, that use broadband light sources at 800 nm and arrayed spectrometers have been provided to facilitate a three-dimensional retinal imaging in vivo with a superior image acquisition speed and a sensitivity to conventional time-domain OCT techniques.
As compared to the SD-OCT techniques, the OFDI procedures offer several advantages, such as an immunity to motion-induced signal fading, simple polarization-sensitive or diversity scheme, and long ranging depth. However, a clinical-viable OFDI system for imaging posterior eye segments has previously been unavailable, primarily due to the lack of a wide-tuning rapidly-swept light source in a low water absorption window. Indeed, despite the widespread use of the conventional OCT for retinal disease diagnostics, imaging posterior eye segment with OFDI has not been possible.
Accordingly, there is a need to overcome the deficiencies as described herein above.
To address and/or overcome the above-described problems and/or deficiencies, exemplary embodiments of systems, arrangements and processes can be provided that are capable of, e.g., utilizing the OFDI techniques to image at least one portion of the eye.
Thus, an exemplary embodiment of OFDI technique, system and process according to the present invention for imaging at least one portion of an eye can be provided. For example, a high-performance swept laser at 1050 nm and an ophthalmic OFDI system can be used that offers a high A-line rate of 19 kHz, sensitivity of >92 dB over a depth range of 2.5 mm with an optical exposure level of 550 μW, and a deep penetration into the choroid. Using the exemplary systems, techniques and arrangements according to the present invention, it is possible to perform comprehensive human retina, optic disk, and choroid imaging in vivo. This can enable a display of a choroidal vasculature in vivo, without exogenous fluorescence contrasts, and may be beneficial for evaluating choroidal as well as retinal diseases. According to another exemplary embodiment of the present invention, an OFDI system can be utilized which uses a swept laser in the 815-870 nm range, which can be used in clinical ophthalmic imaging and molecular contrast-based imaging.
Thus, according to one exemplary embodiment of the present invention, a method, apparatus and software arrangement can be provided for obtaining information associated with an anatomical structure or a sample using optical microscopy. For example, a radiation can be provided which includes at least one first electro-magnetic radiation directed to be provided to an anatomical sample and at least one second electro-magnetic radiation directed to a reference. A wavelength of the radiation can vary over time, and the wavelength is shorter than approximately 1150 nm. An interference can be detected between at least one third radiation associated with the first radiation and at least one fourth radiation associated with the second radiation. At least one image corresponding to at least one portion of the sample can be generated using data associated with the interference.
For example, a period of a variation of the wavelength of the first electro-magnetic radiation can be shorter than 1 millisecond. The anatomical sample can include at least one section of the posterior segment of an eye. The section can include a retina, a choroid, an optic nerve and/or a fovea. The wavelength may be shorter than approximately 950 nm. The wavelength can also vary by at least 10 nm over a period of a variation of the wavelength of the first electromagnetic radiation. At least one fourth arrangement can also be provided which is capable of scanning the first electromagnetic radiation laterally across the anatomical sample. The image may be associated with the anatomical structure of the sample and/or a blood and/or a lymphatic flow in the sample.
In one exemplary variant, the third arrangement may be capable of (i) obtaining at least one signal associated with at least one phase of at least one frequency component of the interference signal over less than an entire sweep of the wavelength, and (ii) comparing the at least one phase to at least one particular information. The particular information can be associated with a further signal obtained from a sweep of the wavelength that is different from the sweep of the wavelength of the signal. The particular information may be a constant, and/or can be associated with at least one phase of at least one further frequency component of the interference signal over less than an entire sweep of the wavelength. The frequency components may be different from one another.
In another exemplary variant, the third arrangement may be capable of generating a two-dimensional fundus-type reflectivity profile of the anatomic sample and/or a two-dimensional fundus-type image of the anatomic sample based the signal. Another arrangement may be provided which is capable of receiving the first or second electromagnetic radiations, and providing at least one fifth electromagnetic radiation associated with the first electromagnetic radiation and/or the second electromagnetic radiation The second arrangement may be further capable of detecting a further interference signal between the fifth radiation and the fourth radiation. The second arrangement may be further capable of obtaining at least one reference signal associated with a further phase of at least one first frequency component of the further interference signal over less than an entire sweep of the wavelength. The particular information may be the further phase.
According to another exemplary embodiment of the present invention, at least one source arrangement can be provided which is configured to provide an electro-magnetic radiation which has a wavelength that varies over time. A period of a variation of the wavelength of the one first electromagnetic radiation can be shorter than 1 millisecond, and the wavelength is shorter than approximately 1150 nm. A control arrangement which is capable of modulating at least one of an optical gain or an optical loss in the at least one source arrangement over time can be provided. The optical gain may be facilitated by a semiconductor material. Another arrangement can be provided which is configured to effect a gain and/or a loss as a function of the wavelength. The wavelength may vary by at least 10 nm over the period and/or may be shorter than approximately 950 nm.
In yet another exemplary embodiment of the present invention, a method, apparatus and software arrangement can be provided. For example, first data can be received for a three-dimensional image of at least one portion of a sample. The first data may be associated with an optical interferometric signal generated from signals obtained from the sample and a reference. A region that is less than an entire portion of the first data can be converted to second data to generate a two-dimensional image which is associated with the portion of the sample. The region can be automatically selected based on at least one characteristic of the sample The entire portion may be associated with an internal structure within the sample (e.g., an anatomical structure). For example, the region may be at least one portion of a retina and/or a choroid. The two-dimensional image may be associated with an integrated reflectivity profile of the region and/or at least one of a blood or a lymphatic vessel network. The region can be automatically selected by determining at least one location of at least one section of the region based a reflectivity in the region.
According to a further exemplary embodiment of the present invention, is possible to cause a radiation to be provided which includes at least one first electro-magnetic radiation directed to a sample and at least one second electromagnetic radiation directed to a reference. A wavelength of the radiation varies over time. An interference signal can be detected between at least one third radiation associated with the first radiation and at least one fourth radiation associated with the second radiation. At least one signal associated with at least one phase of at least one frequency component of the interference signal can be obtained over less than an entire sweep of the wavelength. The phase may be compared to at least one particular information.
In one exemplary variant, the first electromagnetic radiation may be scanned laterally across the sample, which may include at least one section of a posterior segment of an eye. The section can include a retina, a choroid, an optic nerve and/or a fovea. The interference signal may be associated with an integral fraction of the entire sweep of the wavelength. The fraction of the sweep may be a half or a quarter of the sweep. The signal may be associated with a flow velocity and/or an anatomical structure in the sample. The particular information may be associated with a further signal obtained from a sweep of the wavelength that is different from the sweep of the wavelength of the signal. The particular information may be a constant and/or may be associated with at least one phase of at least one further frequency component of the interference signal over less than an entire sweep of the wavelength. The frequency components may be different from one another.
These and other objects, features and advantages of the present invention will become apparent upon reading the following detailed description of embodiments of the invention, when taken in conjunction with the appended claims.
Further objects, features and advantages of the invention will become apparent from the following detailed description taken in conjunction with the accompanying figures showing illustrative embodiments of the invention, in which:
a) is a block diagram of an exemplary embodiment of a wavelength-swept laser system according to the present invention;
b) is a block diagram of an exemplary embodiment of an interferometric system according to the present invention;
a) is a graph illustrating measured output characteristics of a peak-hold output spectrum and an optical absorption in water for a particular propagation distance corresponding to a roundtrip in typical human vitreous;
b) is a graph illustrating measured output characteristics of a time-domain output trace;
a) is a first exemplary OFDI image at fovea and optic nerve head of a patient A produced by an exemplary system at one location;
b) is a second exemplary OFDI image at the fovea and the optic nerve head of the patient A produced by another exemplary system at such location;
c) is a first exemplary SD-OCT image at the fovea and the optic nerve head of the patient A as a similar location produced by an exemplary system according to the present invention;
d) is a second exemplary SD-OCT image at the fovea and the optic nerve head of the patient A as the location of
e) is a third exemplary OFDI image obtained from a patient B produced by another exemplary system according to the present invention;
f) is a fourth exemplary OFDI image obtained from the patient B produced by a further exemplary system according to the present invention;
a) is a schematic diagram of an exemplary embodiment of the wavelength-swept laser arrangement according to the present invention;
b) is a graph of a peak-hold output spectrum of the signals generated using the exemplary embodiment of
c) is a graph of a oscilloscope trace generated using the exemplary embodiment of
a) is a graph of a sensitivity measured as a function of a reference power;
b) is a graph of a sensitivity measured as a function of a depth;
a) is a graph of an exemplary output of a shaped spectra without a gain/loss modulation generated as a function of wavelength using another exemplary embodiment of the system, arrangement and process according to the present invention;
b) is a graph of an exemplary output of the shaped spectra with the gain/loss modulation generated as a function of wavelength using an exemplary embodiment of the system, arrangement and process according to the present invention;
a) is an exemplary single image of the retina which includes the fovea and optic disk obtained from a healthy volunteer consecutively acquired at a large number of frames; and
b) is an exemplary integrated lindus image of the retina generated from multiple cross-sectional images covering an area by integrating the intensity in each depth profile.
Throughout the figures, the same reference numerals and characters, unless otherwise stated, are used to denote like features, elements, components or portions of the illustrated embodiments. Moreover, while the subject invention will now be described in detail with reference to the figures, it is done so in connection with the illustrative embodiments. It is intended that changes and modifications can be made to the described embodiments without departing from the true scope and spirit of the subject invention as defined by the appended claims.
First Exemplary Embodiment of Laser Source System
a) depicts an exemplary embodiment of a laser source system (e.g., which can include a 1050 nm swept laser source) provided in a linear cavity configuration according to the present invention. As shown in this figure, a gain medium 10 can be provided, such as a bi-directional semiconductor optical amplifier (QPhotonics, Inc., QSOA-1050) which may be driven at an injection current level of 400 mA. One port of the amplifier can be coupled to a wavelength-scanning filter 20 that may comprise a diffraction grating 30 (1200 lines/mm), a telescope consisting of two lenses 40, 42 with respective focal lengths of 100 and 50 mm, and a polygon mirror scanner 50 (e.g., Lincoln Lasers, Inc., 40 facets). The design bandwidth and free spectral range of the filter can be approximately 0.1 nm and 61 nm, respectively. The amplifier's other port can be spliced to connect to a loop mirror which may include a 50/50 coupler 60. A Sagnac loop 70 can also act as an output coupler.
The reflectivity and output coupling ratio can be complementary, and may be optimized by adjusting a polarization controller 80 to tune the amount of the birefringence-induced non-reciprocity in the loop. The linear-cavity configuration can also be used instead of or together with conventional ring cavity designs, since low-loss low-cost circulators and isolators may not be readily available at 1050 nm. Sweep repetition rates of up to 36 kHz may be achieved with 100% duty cycle, which may represent a significant improvement over previously demonstrated swept lasers in the 1050 nm region that offered tuning rates of <1 kHz. In an OFDI system according to one exemplary embodiment of the present invention, the laser can be operated at a wavelength sweep rate of about 18.8 kHz, thus producing a polarized output with an average output power of 2.7 mW.
Exemplary Embodiment of Imaging System
b) depicts an exemplary embodiment of an optical frequency domain imaging (OFDI) system according to the present invention. For example, it is possible to use a swept laser can be used as a light source 100. This exemplary system further comprises a fiber-optic interferometer 110, a beam scanner 120, a detector 130 and a computer 140. A sample arm 150 (e.g., 30% port) can be connected to a two-axis galvanometer scanner apparatus 120 which may be designed for a retinal imaging. A focal beam size can be approximately 10 μm in tissue (e.g., index=1.38). The optical power level at an entrance pupil of an eye 160 can be measured to be about 550 μW, which is well below the 1.9-mW maximum exposure level at λ=1050 nm according to the ANSI laser safety standards. A reference arm 170 (e.g., 70% port) can utilize a transmission-type variable delay line 180 and a 10% tap coupler 182 to generate sampling trigger signals for acquiring data.
As shown in
Exemplary Laser Output Characteristics
a) depicts an exemplary output spectrum measured using an optical spectrum analyzer in peak-hold mode (with resolution=0.1 nm). The exemplary output spectrum spanned from 1019 to 1081 nm over a range of 62 nm determined by the free spectral range of the filter. The spectral range coincided with a local transparent window of the eye. The roundtrip optical absorption in human vitreous and aqueous humors can be estimated to be between about 2 dB and 5 dB based on known absorption characteristics of water (as shown in
b) shows a graph of a time domain exemplary oscilloscope output trace 210 of a laser output indicating 100% tuning duty cycle at 18.8 kHz (single shot, 5-MHz detection bandwidth). The y-axis of the trace graph of
Exemplary Sensitivity and Resolution of Imaging System
An exemplary embodiment of the OFDI system and exemplary optimized operating parameters can be provided to maximize the SNR using a partial reflector (neutral density filter and metal mirror) as a sample. An exemplary preferable reference arm power for maximal SNR may be 2.6 μW at each detection port. This relatively low value can be attributed to the relatively large intensity noise of the laser that may not be completely suppressed in the dual balanced detection. Exemplary data processing according to an exemplary embodiment of the present invention can include reference subtraction, envelope apodization or windowing, interpolation to correct for nonlinear k-space tuning, and dispersion correction. For example, subtracting the reference from the interference signals can eliminate image artifacts due to a non-uniform spectral envelope of the laser source. Apodizing the interference fringes by imposing a appropriate windowing technique can decrease the sidebands of point spread functions and improve image contrast.
This exemplary embodiment of the process according to the present invention may come at a resolution loss and SNR (due to a reduced integration time). It is possible to use a Gaussian window to yield a desirable compromise in contrast and resolution (e.g., at 1050-nm). Since the detector signal may not be sampled in constant time intervals, whereas the tuning curve of our laser was not linear in k-space, interpolating the interference signal may be preferable to reduce or avoid image blurring. Upon completing the exemplary interpolation, the signal may be further corrected for the chromatic dispersion in the interferometer as well as in the sample, e.g., by multiplying a predetermined phase function.
As indicated in
Exemplary Video-rate Imaging of Retina, Optic Disk, and Choroid in Vivo
Exemplary OFDI imaging was conducted on two healthy volunteers (A: 36-year-old Asian male, B: 41-year-old Caucasian male) using the exemplary embodiments of the system, process and arrangement according to the present invention. The exemplary OFDI system acquired 18,800 A-lines continuously over 10-20 seconds as the focused sample beam was scanned over an area of 6 mm (horizontal) by 5.2 mm (vertical) across the macular region in the retina.
To assess the penetration of the exemplary embodiments of the system, process and arrangement according to the present invention, the two volunteers A and B can be three-dimensionally imaged using both the OFDI system and the SD-OCT system previously developed for video-rate retinal imaging. The SD-OCT system employed a super luminescent diode with a center wavelength of 840 nm and a 3-dB spectral bandwidth of 50 nm, offering an axial resolution of 8-9 nm in air. At an A-line rate of 29 kHz and a sample arm power level of 600 μW, the SD-OCT system offered a peak sensitivity of 98 dB at zero delay that decreased to 82 dB at the maximum ranging depth of 2.2 mm in air.
As shown in these figures, the OFDI images exhibit considerably deeper penetration into the choroid compared to the SD-OCT images, whereas the higher axial resolution in the SD-OCT images provide better contrast between retinal layers. The lower absorption and scattering in RPE at 1050 nm than 840 nm may account for the apparently superior penetration of the OFDI system to the SD-OCT system with a comparable sensitivity.
Visualization of Retinal/Choroidal Vasculature with OFDI Techniques/Systems
With the three-dimensional tomographic data of the eye's posterior segment, the pixel values along the entire depth axis can be integrated to produce a two-dimensional fundus-type reflectivity image.
For example, according to one exemplary embodiment of the present invention, in order to visualize the retinal vasculature with a maximum contrast, it is possible to integrate the reflectivity in the range between IPRL and RPE 260, 270 as shown in
Exemplary Implementation of Exemplary Embodiments of Invention
Experimental results show that the images generated using the exemplary OFDI techniques at 1050 nm can provide a comprehensive imaging of the human retina and choroid with high resolution and contrast. However, the exemplary embodiment of the OFDI system according to the exemplary embodiments of the present invention may provide an order-of-magnitude higher image acquisition speed than with the use of the conventional time-domain OCT systems, and avails the choroid images with an enhanced contrast in comparison to the SD-OCT system at 840 nm. The enhanced penetration makes it possible to obtain depth-sectioned reflectivity images of the choroid capillary and vascular networks. Fundus camera or scanning laser ophthalmoscope have been conventionally used to view vasculatures. However, such methods may require fluoresce in or indocyanine green angiography to have access to the choroid except for patients with significantly low level of pigmentations.
The exemplary OFDI system according to the present invention includes a wavelength-swept laser produced using, e.g., a commercial SOA and custom-built intracavity scanning filter, such laser's output power, tuning speed and range may yield a sensitivity of about 98 dB, A-line rate of 19 kHz, and resolution of 10 μm in tissue. Increasing the saturation power and gain of SOA and reducing the extended-cavity loss can possibly further improve the sensitivity and resolution (tuning range). For example, the power exposure level of the exemplary embodiment of the system according to the present invention can be only 550 μW, whereas the maximum ANSI limit at 1050 nm is likely to be 1.9 mW.
Exemplary Embodiment of Swept Laser Source
a) shows another exemplary embodiment of a swept laser source arrangement according to the present invention, e.g., in the 815-870 nm spectral range. The swept laser source arrangement can include a fiber-optic unidirectional ring cavity 300 with a free-space isolator 310. The gain medium 320 may be a commercially-available semiconductor optical amplifier (e.g., SOA-372-850-SM, Superlum Diodes Ltd.). An intracavity spectral filter 330 can be provided which may comprise a diffractive grating (e.g., 830 grooves/mm) 332, two achromatic lenses 334, 336 in the 4f configuration, and a 72-facet polygon mirror 340 (Lincoln lasers, Inc.). The polygon can be rotated at about 600 revolutions per second to produce unidirectional sweeps from short to long wavelengths at a repetition rate of 43.2 kHz.
The free-space collimated beam in the cavity may have a size of about 1 mm FWHM (full width at half maximum). The beam incident angle to the grating normal can be 67 deg. The focal lengths of the two lenses 334, 336 in the telescope can be 75 (f1) and 40 (f2) mm, respectively. It is possible to predict a free-spectral range of 55 nm and FWHM filter bandwidth of 0.17 nm. The laser output can be obtained via a 70% port of a fiber-optic coupler 350. Two polarization controllers 360, 362 can be used to maximize the output power and tuning range.
For example, it is possible to measure the spectral and temporal characteristics of the laser output at a sweep rate of about 43.2 kHz. The SOA may be driven with an injection current of about 110 mA.
An exemplary measurement of the coherence length (as shown in
The large output coupling ratio of the exemplary embodiment of the laser source arrangement, e.g., about 70%, can ensure that the peak power at the SOA does not exceed about 20 mW, e.g., the specified optical damage threshold of the SOA. When this condition is not satisfied, a sudden catastrophic or slowly progressing damage may occur at the output facet of SOA chip. Increasing the optical damage threshold of the 800-nm SOA chips, e.g., by new chip designs, can improve the tuning range as well as the long-term reliability. The output may contain a broadband amplified spontaneous emission that can occupy ˜8% (about 0.56 mW) of the total average power.
Exemplary Imaging System
An exemplary embodiment of the OFDI system according to the present invention can be provided using the exemplary wavelength-swept laser arrangement. The configuration of the exemplary system can be similar to the system shown in
The interference signal may be detected with a dual-balanced silicon receiver (e.g., DC-80 MHz, 1807-FS, New Focus). The receiver output is low-pass filtered (35 MHz) and digitized at a sampling rate of 100 MS/s with a 14-bit data acquisition board (e.g., DAQ, NI-5122, National Instruments). A small portion (10%) of the reference beam can be tapped and detected through a grating filter to provide triggers to the DAQ board. During each wavelength sweep or A-line scan, a large number, e.g., 2048 samples can be acquired. The sampled data may initially be stored in an on-board memory or on another storage device.
Upon collecting a desired number of A-line scans, the data set may be transferred to a host personal computer, either to the memory/storage arrangement for on-line processing and/or display or to the hard disk for post processing. When only a single frame is acquired at a time, the exemplary system is capable of processing and displaying the image frame in real time at a frame refresh rate of about 5 Hz. For larger data sets, an exemplary 256 MB on-board memory provides for acquisition of up to 65,536 A-line scans consecutively for about 1.3 sec. This corresponds to about 128 image frames, each consisting of 512 A-lines. Post data processing techniques can include reference subtraction, apodization, interpolation into a linear k-space, and dispersion compensation prior to Fourier transforms.
To characterize and optimize the exemplary embodiment of the system, process and arrangement according to the present invention, it is possible to use an axial point spread function (or A-line) by using a partial mirror as the sample (−50 dB reflectivity).
The sensitivity in the unit of decibel may be expressed as: SdB=S0−10 log10(1+a/Pr+Pr/b)−Δ, where S0 denotes the shot-noise limited sensitivity, Pr is the reference power level, a and b correspond to the reference power levels at which the thermal and intensity noise, respectively, become equal to that of the shot noise in magnitude, and Δ can be a fitting parameter associated with other factors contributing to the loss of sensitivity. Taking into account amplified spontaneous emission, S0 may be about 107 dB. For example, a=17 μW from the detector noise level (e.g., 3.3 pA/√Hz) and conversion efficiency (e.g., 1 A/W). Based on the relative intensity noise of the laser (e.g., −130 dB/Hz) and an 18-dB common-noise suppression efficiency of the balanced receiver, b=280 μW. For example, the best fit to the experimental data 410 of
Due to a finite coherence length of the laser source, the sensitivity can decrease as the interferometric delay increases. It is possible to measure axial point spread functions at various depth locations of the sample mirror by changing the delay in the reference arm while maintaining the reference power at about 100 μW per photodiode, as shown in the graph of
As an example, to confirm and demonstrate the capabilities of the exemplary embodiment of the system, process and arrangement according to the present invention for high-speed high-resolution biological imaging, images of Xenopus laevis tadpoles may be obtained in vivo by scanning the sample beam (B-mode scan). The sample beam can have a confocal parameter of about 250 μm and a FWHM beam size of approximately 7 μm at the focus in air (n=1). The optical power on the sample may be about 2.4 mW. During the imaging procedure, the tadpole (stage 46) can be under anesthesia in a water bath by a drop of about 0.02% 3-aminobenzoic acid ethyl ester (MS-222).
Exemplary Laser Current Modulation
An exemplary preferred light source arrangement for OFDI imaging generally has a flat output spectrum. To obtain such desired spectral profile, it is possible to modulate the gain or loss of a gain medium or a filter inside or outside a laser cavity. The filter may be a broadband variable attenuator, and its transmission may be controlled synchronously with laser tuning. The exemplary filter may be a passive spectral filter with a desired transmission spectrum. The gain medium can preferably be a semiconductor optical amplifier, and its gain may be varied by modulating the injection current to the amplifier synchronously with filter tuning.
Exemplary Flow Measurement
The ability to detect and quantify the blood flow in the eye retina and choroid can have impacts in several clinical applications such as for an evaluation of age-related macular degeneration. Several methods of extracting the flow information from the phase of the OFDI signals are known in the art. These exemplary conventional methods, however, require a significant beam overlap between two consecutive A-line scans- over sampling, thus causing undesirable compromise between the phase accuracy and image acquisition speed. Using the exemplary embodiment of the system, process and arrangement according to the present invention, instead of comparing the phase values of two A-line scans, it is possible to extract multiple phase values corresponding to different time points or wavelengths within a single A-line and compare the values with reference phase values. This exemplary procedure provides for a measurement of the flow velocity at multiple time points during a single A-line scan, permitting a faster beam scan and image acquisition speed. Such procedure can be used at decreased phase or velocity measurement accuracy, which is likely to be acceptable in many applications.
a) and 13(b) show exemplary images image of the retina obtained from a healthy volunteer. For example,
As shown in these figures, the retinal OFDI imaging was performed at 800-900 nm in vivo on a 41-year-old Caucasian male subject. The exemplary embodiment of the OFDI system, process and arrangement according to the present invention acquired 23 k A-lines continuously over 1-2 seconds as the focused sample beam was scanned over an area including the macular and optic nerve head region in the retina. Each image frame was constructed from 1,000 A-line scans with an inverse grayscale table mapping to the reflectivity range. The anatomical layers in the retina are clearly visualized and correlate well with previously published OCT images and histological findings.
The foregoing merely illustrates the principles of the invention. Various modifications and alterations to the described embodiments will be apparent to those skilled in the art in view of the teachings herein. Indeed, the arrangements, systems and methods according to the exemplary embodiments of the present invention can be used with any OCT system, OFDI system, SD-OCT system or other imaging systems, and for example with those described in International Patent Application PCT/US2004/029148, filed Sep. 8, 2004, U.S. patent application Ser. No. 11/266,779, filed Nov. 2, 2005, and U.S. patent application Ser. No. 10/501,276, filed Jul. 9, 2004, the disclosures of which are incorporated by reference herein in their entireties. It will thus be appreciated that those skilled in the art will be able to devise numerous systems, arrangements and methods which, although not explicitly shown or described herein, embody the principles of the invention and are thus within the spirit and scope of the present invention. In addition, to the extent that the prior art knowledge has not been explicitly incorporated by reference herein above, it is explicitly being incorporated herein in its entirety. All publications referenced herein above are incorporated herein by reference in their entireties.
This application is based upon and claims the benefit of priority from U.S. patent application Ser. No. 60/799,511, filed May 10, 2006, the entire disclosure of which is incorporated herein by reference.
The research leading to the present invention was supported, at least in part, by National Institute of Health-National Cancer Institute, Grant number R33 214033. Thus, the U.S. government may have certain rights in the invention.
Number | Name | Date | Kind |
---|---|---|---|
2339754 | Brace | Jan 1944 | A |
3090753 | Matuszak et al. | May 1963 | A |
3601480 | Randall | Aug 1971 | A |
3856000 | Chikama | Dec 1974 | A |
3872407 | Hughes | Mar 1975 | A |
3941121 | Olinger | Mar 1976 | A |
3973219 | Tang et al. | Aug 1976 | A |
3983507 | Tang et al. | Sep 1976 | A |
4030827 | Delhaye et al. | Jun 1977 | A |
4030831 | Gowrinathan | Jun 1977 | A |
4140364 | Yamashita et al. | Feb 1979 | A |
4141362 | Wurster | Feb 1979 | A |
4224929 | Furihata | Sep 1980 | A |
4295738 | Meltz et al. | Oct 1981 | A |
4300816 | Snitzer et al. | Nov 1981 | A |
4303300 | Pressiat et al. | Dec 1981 | A |
4428643 | Kay | Jan 1984 | A |
4479499 | Alfano | Oct 1984 | A |
4533247 | Epworth | Aug 1985 | A |
4585349 | Gross et al. | Apr 1986 | A |
4601036 | Faxvog et al. | Jul 1986 | A |
4607622 | Fritch et al. | Aug 1986 | A |
4631498 | Cutler | Dec 1986 | A |
4639999 | Daniele | Feb 1987 | A |
4650327 | Ogi | Mar 1987 | A |
4734578 | Horikawa | Mar 1988 | A |
4744656 | Moran et al. | May 1988 | A |
4751706 | Rohde et al. | Jun 1988 | A |
4763977 | Kawasaki et al. | Aug 1988 | A |
4770492 | Levin et al. | Sep 1988 | A |
4827907 | Tashiro et al. | May 1989 | A |
4834111 | Khanna et al. | May 1989 | A |
4868834 | Fox et al. | Sep 1989 | A |
4890901 | Cross, Jr. | Jan 1990 | A |
4892406 | Waters | Jan 1990 | A |
4905169 | Buican et al. | Feb 1990 | A |
4909631 | Tan et al. | Mar 1990 | A |
4925302 | Cutler | May 1990 | A |
4928005 | Lefèvre et al. | May 1990 | A |
4940328 | Hartman | Jul 1990 | A |
4965441 | Picard | Oct 1990 | A |
4965599 | Roddy et al. | Oct 1990 | A |
4966589 | Kaufman | Oct 1990 | A |
4984888 | Tobias et al. | Jan 1991 | A |
4993834 | Carlhoff et al. | Feb 1991 | A |
4998972 | Chin et al. | Mar 1991 | A |
5039193 | Snow et al. | Aug 1991 | A |
5040889 | Keane | Aug 1991 | A |
5045936 | Lobb et al. | Sep 1991 | A |
5046501 | Crilly | Sep 1991 | A |
5065331 | Vachon et al. | Nov 1991 | A |
5085496 | Yoshida et al. | Feb 1992 | A |
5120953 | Harris | Jun 1992 | A |
5121983 | Lee | Jun 1992 | A |
5127730 | Brelje et al. | Jul 1992 | A |
5197470 | Helfer et al. | Mar 1993 | A |
5202745 | Sorin et al. | Apr 1993 | A |
5202931 | Bacus et al. | Apr 1993 | A |
5208651 | Buican | May 1993 | A |
5212667 | Tomlinson et al. | May 1993 | A |
5214538 | Lobb | May 1993 | A |
5217456 | Narciso, Jr. | Jun 1993 | A |
5228001 | Birge et al. | Jul 1993 | A |
5241364 | Kimura et al. | Aug 1993 | A |
5248876 | Kerstens et al. | Sep 1993 | A |
5250186 | Dollinger et al. | Oct 1993 | A |
5251009 | Bruno | Oct 1993 | A |
5262644 | Maguire | Nov 1993 | A |
5275594 | Baker | Jan 1994 | A |
5281811 | Lewis | Jan 1994 | A |
5283795 | Fink | Feb 1994 | A |
5291885 | Taniji et al. | Mar 1994 | A |
5293872 | Alfano et al. | Mar 1994 | A |
5293873 | Fang | Mar 1994 | A |
5302025 | Kleinerman | Apr 1994 | A |
5304173 | Kittrell et al. | Apr 1994 | A |
5304810 | Amos | Apr 1994 | A |
5305759 | Kaneko et al. | Apr 1994 | A |
5317389 | Hochberg et al. | May 1994 | A |
5318024 | Kittrell et al. | Jun 1994 | A |
5321501 | Swanson et al. | Jun 1994 | A |
5348003 | Caro | Sep 1994 | A |
5353790 | Jacques et al. | Oct 1994 | A |
5383467 | Auer et al. | Jan 1995 | A |
5394235 | Takeuchi et al. | Feb 1995 | A |
5404415 | Mori et al. | Apr 1995 | A |
5411016 | Kume et al. | May 1995 | A |
5419323 | Kittrell et al. | May 1995 | A |
5424827 | Horwitz et al. | Jun 1995 | A |
5439000 | Gunderson et al. | Aug 1995 | A |
5441053 | Lodder et al. | Aug 1995 | A |
5450203 | Penkethman | Sep 1995 | A |
5454807 | Lennox et al. | Oct 1995 | A |
5459325 | Hueton et al. | Oct 1995 | A |
5459570 | Swanson et al. | Oct 1995 | A |
5465147 | Swanson | Nov 1995 | A |
5486701 | Norton et al. | Jan 1996 | A |
5491524 | Hellmuth et al. | Feb 1996 | A |
5491552 | Knuttel | Feb 1996 | A |
5522004 | Djupsjobacka et al. | May 1996 | A |
5526338 | Hasman et al. | Jun 1996 | A |
5555087 | Miyagawa et al. | Sep 1996 | A |
5562100 | Kittrell et al. | Oct 1996 | A |
5565983 | Barnard et al. | Oct 1996 | A |
5565986 | Knüttel | Oct 1996 | A |
5566267 | Neuberger | Oct 1996 | A |
5583342 | Ichie | Dec 1996 | A |
5590660 | MacAulay et al. | Jan 1997 | A |
5600486 | Gal et al. | Feb 1997 | A |
5601087 | Gunderson et al. | Feb 1997 | A |
5621830 | Lucey et al. | Apr 1997 | A |
5623336 | Raab et al. | Apr 1997 | A |
5635830 | Itoh | Jun 1997 | A |
5649924 | Everett et al. | Jul 1997 | A |
5697373 | Richards-Kortum et al. | Dec 1997 | A |
5698397 | Zarling et al. | Dec 1997 | A |
5710630 | Essenpreis et al. | Jan 1998 | A |
5716324 | Toida | Feb 1998 | A |
5719399 | Alfano et al. | Feb 1998 | A |
5730731 | Mollenauer et al. | Mar 1998 | A |
5735276 | Lemelson | Apr 1998 | A |
5740808 | Panescu et al. | Apr 1998 | A |
5748318 | Maris et al. | May 1998 | A |
5748598 | Swanson et al. | May 1998 | A |
5752518 | McGee et al. | May 1998 | A |
5784352 | Swanson et al. | Jul 1998 | A |
5785651 | Kuhn et al. | Jul 1998 | A |
5795295 | Hellmuth et al. | Aug 1998 | A |
5801826 | Williams | Sep 1998 | A |
5801831 | Sargoytchev et al. | Sep 1998 | A |
5803082 | Stapleton et al. | Sep 1998 | A |
5807261 | Benaron et al. | Sep 1998 | A |
5810719 | Toida | Sep 1998 | A |
5817144 | Gregory | Oct 1998 | A |
5836877 | Zavislan et al. | Nov 1998 | A |
5840023 | Oraevsky et al. | Nov 1998 | A |
5840075 | Mueller et al. | Nov 1998 | A |
5842995 | Mahadevan-Jansen et al. | Dec 1998 | A |
5843000 | Nishioka et al. | Dec 1998 | A |
5843052 | Benja-Athon | Dec 1998 | A |
5847827 | Fercher | Dec 1998 | A |
5862273 | Pelletier | Jan 1999 | A |
5865754 | Sevick-Muraca et al. | Feb 1999 | A |
5867268 | Gelikonov et al. | Feb 1999 | A |
5871449 | Brown | Feb 1999 | A |
5872879 | Hamm | Feb 1999 | A |
5877856 | Fercher | Mar 1999 | A |
5887009 | Mandella et al. | Mar 1999 | A |
5892583 | Li | Apr 1999 | A |
5910839 | Erskine et al. | Jun 1999 | A |
5912764 | Togino | Jun 1999 | A |
5920373 | Bille | Jul 1999 | A |
5920390 | Farahi et al. | Jul 1999 | A |
5921926 | Rolland et al. | Jul 1999 | A |
5926592 | Harris et al. | Jul 1999 | A |
5949929 | Hamm | Sep 1999 | A |
5951482 | Winston et al. | Sep 1999 | A |
5955737 | Hallidy et al. | Sep 1999 | A |
5956355 | Swanson et al. | Sep 1999 | A |
5968064 | Selmon et al. | Oct 1999 | A |
5975697 | Podoleanu et al. | Nov 1999 | A |
5983125 | Alfano et al. | Nov 1999 | A |
5987346 | Benaron et al. | Nov 1999 | A |
5991697 | Nelson et al. | Nov 1999 | A |
5994690 | Kulkarni et al. | Nov 1999 | A |
5995223 | Power | Nov 1999 | A |
6002480 | Izatt et al. | Dec 1999 | A |
6004314 | Wei et al. | Dec 1999 | A |
6006128 | Izatt et al. | Dec 1999 | A |
6007996 | McNamara et al. | Dec 1999 | A |
6010449 | Selmon et al. | Jan 2000 | A |
6014214 | Li | Jan 2000 | A |
6016197 | Krivoshlykov | Jan 2000 | A |
6020963 | Dimarzio et al. | Feb 2000 | A |
6025956 | Nagano et al. | Feb 2000 | A |
6033721 | Nassuphis | Mar 2000 | A |
6037579 | Chan et al. | Mar 2000 | A |
6044288 | Wake et al. | Mar 2000 | A |
6045511 | Ott et al. | Apr 2000 | A |
6048742 | Weyburne et al. | Apr 2000 | A |
6053613 | Wei et al. | Apr 2000 | A |
6069698 | Ozawa et al. | May 2000 | A |
6078047 | Mittleman et al. | Jun 2000 | A |
6091496 | Hill | Jul 2000 | A |
6091984 | Perelman et al. | Jul 2000 | A |
6094274 | Yokoi | Jul 2000 | A |
6107048 | Goldenring et al. | Aug 2000 | A |
6111645 | Tearney et al. | Aug 2000 | A |
6117128 | Gregory | Sep 2000 | A |
6120516 | Selmon et al. | Sep 2000 | A |
6134003 | Tearney et al. | Oct 2000 | A |
6134010 | Zavislan | Oct 2000 | A |
6134033 | Bergano et al. | Oct 2000 | A |
6141577 | Rolland et al. | Oct 2000 | A |
6151522 | Alfano et al. | Nov 2000 | A |
6159445 | Klaveness et al. | Dec 2000 | A |
6160826 | Swanson et al. | Dec 2000 | A |
6161031 | Hochmann et al. | Dec 2000 | A |
6166373 | Mao | Dec 2000 | A |
6174291 | McMahon et al. | Jan 2001 | B1 |
6175669 | Colston et al. | Jan 2001 | B1 |
6185271 | Kinsinger | Feb 2001 | B1 |
6191862 | Swanson et al. | Feb 2001 | B1 |
6193676 | Winston et al. | Feb 2001 | B1 |
6198956 | Dunne | Mar 2001 | B1 |
6201989 | Whitehead et al. | Mar 2001 | B1 |
6208415 | De Boer et al. | Mar 2001 | B1 |
6208887 | Clarke | Mar 2001 | B1 |
6245026 | Campbell et al. | Jun 2001 | B1 |
6249349 | Lauer | Jun 2001 | B1 |
6249381 | Suganuma | Jun 2001 | B1 |
6249630 | Stock et al. | Jun 2001 | B1 |
6263234 | Engelhardt et al. | Jul 2001 | B1 |
6264610 | Zhu | Jul 2001 | B1 |
6272376 | Marcu et al. | Aug 2001 | B1 |
6274871 | Dukor et al. | Aug 2001 | B1 |
6282011 | Tearney et al. | Aug 2001 | B1 |
6297018 | French et al. | Oct 2001 | B1 |
6301048 | Cao et al. | Oct 2001 | B1 |
6308092 | Hoyns | Oct 2001 | B1 |
6324419 | Guzelsu et al. | Nov 2001 | B1 |
6341036 | Tearney et al. | Jan 2002 | B1 |
6353693 | Kano et al. | Mar 2002 | B1 |
6359692 | Groot | Mar 2002 | B1 |
6374128 | Toida et al. | Apr 2002 | B1 |
6377349 | Fercher | Apr 2002 | B1 |
6384915 | Everett et al. | May 2002 | B1 |
6393312 | Hoyns | May 2002 | B1 |
6394964 | Sievert, Jr. et al. | May 2002 | B1 |
6396941 | Bacus et al. | May 2002 | B1 |
6421164 | Tearney et al. | Jul 2002 | B2 |
6437867 | Zeylikovich et al. | Aug 2002 | B2 |
6441892 | Xiao et al. | Aug 2002 | B2 |
6441959 | Yang et al. | Aug 2002 | B1 |
6445485 | Frigo et al. | Sep 2002 | B1 |
6445939 | Swanson et al. | Sep 2002 | B1 |
6445944 | Ostrovsky | Sep 2002 | B1 |
6459487 | Chen et al. | Oct 2002 | B1 |
6463313 | Winston et al. | Oct 2002 | B1 |
6469846 | Ebizuka et al. | Oct 2002 | B2 |
6475159 | Casscells et al. | Nov 2002 | B1 |
6475210 | Phelps et al. | Nov 2002 | B1 |
6477403 | Eguchi et al. | Nov 2002 | B1 |
6485413 | Boppart et al. | Nov 2002 | B1 |
6485482 | Belef | Nov 2002 | B1 |
6501551 | Tearney et al. | Dec 2002 | B1 |
6501878 | Hughes et al. | Dec 2002 | B2 |
6516014 | Sellin et al. | Feb 2003 | B1 |
6517532 | Altshuler et al. | Feb 2003 | B1 |
6538817 | Farmer et al. | Mar 2003 | B1 |
6540391 | Lanzetta et al. | Apr 2003 | B2 |
6549801 | Chen et al. | Apr 2003 | B1 |
6552796 | Magnin et al. | Apr 2003 | B2 |
6556305 | Aziz et al. | Apr 2003 | B1 |
6556853 | Cabib et al. | Apr 2003 | B1 |
6558324 | Von Behren et al. | May 2003 | B1 |
6564087 | Pitris et al. | May 2003 | B1 |
6564089 | Izatt et al. | May 2003 | B2 |
6567585 | Harris | May 2003 | B2 |
6593101 | Richards-Kortum et al. | Jul 2003 | B2 |
6611833 | Johnson et al. | Aug 2003 | B1 |
6615071 | Casscells, III et al. | Sep 2003 | B1 |
6622732 | Constantz | Sep 2003 | B2 |
6654127 | Everett et al. | Nov 2003 | B2 |
6657730 | Pfau et al. | Dec 2003 | B2 |
6658278 | Gruhl | Dec 2003 | B2 |
6680780 | Fee | Jan 2004 | B1 |
6685885 | Nolte et al. | Feb 2004 | B2 |
6687007 | Meigs | Feb 2004 | B1 |
6687010 | Horii et al. | Feb 2004 | B1 |
6687036 | Riza | Feb 2004 | B2 |
6692430 | Adler | Feb 2004 | B2 |
6701181 | Tang et al. | Mar 2004 | B2 |
6721094 | Sinclair et al. | Apr 2004 | B1 |
6738144 | Dogariu et al. | May 2004 | B1 |
6741355 | Drabarek | May 2004 | B2 |
6757467 | Rogers | Jun 2004 | B1 |
6790175 | Furusawa et al. | Sep 2004 | B1 |
6806963 | Wälti et al. | Oct 2004 | B1 |
6816743 | Moreno et al. | Nov 2004 | B2 |
6831781 | Tearney et al. | Dec 2004 | B2 |
6839496 | Mills et al. | Jan 2005 | B1 |
6882432 | Deck | Apr 2005 | B2 |
6900899 | Nevis | May 2005 | B2 |
6903820 | Wang | Jun 2005 | B2 |
6909105 | Heintzmann et al. | Jun 2005 | B1 |
6949072 | Furnish et al. | Sep 2005 | B2 |
6961123 | Wang et al. | Nov 2005 | B1 |
6980299 | de Boer | Dec 2005 | B1 |
6996549 | Zhang et al. | Feb 2006 | B2 |
7006231 | Ostrovsky et al. | Feb 2006 | B2 |
7006232 | Rollins et al. | Feb 2006 | B2 |
7019838 | Izatt et al. | Mar 2006 | B2 |
7027633 | Foran et al. | Apr 2006 | B2 |
7061622 | Rollins et al. | Jun 2006 | B2 |
7072047 | Westphal et al. | Jul 2006 | B2 |
7075658 | Izatt et al. | Jul 2006 | B2 |
7099358 | Chong et al. | Aug 2006 | B1 |
7113288 | Fercher | Sep 2006 | B2 |
7113625 | Watson et al. | Sep 2006 | B2 |
7130320 | Tobiason et al. | Oct 2006 | B2 |
7139598 | Hull et al. | Nov 2006 | B2 |
7142835 | Paulus | Nov 2006 | B2 |
7148970 | De Boer | Dec 2006 | B2 |
7177027 | Hirasawa et al. | Feb 2007 | B2 |
7190464 | Alphonse | Mar 2007 | B2 |
7230708 | Lapotko et al. | Jun 2007 | B2 |
7231243 | Tearney et al. | Jun 2007 | B2 |
7236637 | Sirohey et al. | Jun 2007 | B2 |
7242480 | Alphonse | Jul 2007 | B2 |
7267494 | Deng et al. | Sep 2007 | B2 |
7272252 | De La Torre-Bueno et al. | Sep 2007 | B2 |
7304798 | Izumi et al. | Dec 2007 | B2 |
7330270 | O'Hara et al. | Feb 2008 | B2 |
7336366 | Choma et al. | Feb 2008 | B2 |
7342659 | Horn et al. | Mar 2008 | B2 |
7355716 | De Boer et al. | Apr 2008 | B2 |
7355721 | Quadling et al. | Apr 2008 | B2 |
7359062 | Chen et al. | Apr 2008 | B2 |
7366376 | Shishkov et al. | Apr 2008 | B2 |
7382809 | Chong et al. | Jun 2008 | B2 |
7391520 | Zhou et al. | Jun 2008 | B2 |
7458683 | Chernyak et al. | Dec 2008 | B2 |
7530948 | Seibel et al. | May 2009 | B2 |
7539530 | Caplan et al. | May 2009 | B2 |
7609391 | Betzig | Oct 2009 | B2 |
7630083 | de Boer et al. | Dec 2009 | B2 |
7643152 | de Boer et al. | Jan 2010 | B2 |
7643153 | de Boer et al. | Jan 2010 | B2 |
7646905 | Guittet et al. | Jan 2010 | B2 |
7649160 | Colomb et al. | Jan 2010 | B2 |
7664300 | Lange et al. | Feb 2010 | B2 |
7733497 | Yun et al. | Jun 2010 | B2 |
7782464 | Mujat et al. | Aug 2010 | B2 |
7805034 | Kato et al. | Sep 2010 | B2 |
20010036002 | Tearney et al. | Nov 2001 | A1 |
20010047137 | Moreno et al. | Nov 2001 | A1 |
20020016533 | Marchitto et al. | Feb 2002 | A1 |
20020024015 | Hoffmann et al. | Feb 2002 | A1 |
20020044280 | Weigold et al. | Apr 2002 | A1 |
20020048025 | Takaoka | Apr 2002 | A1 |
20020048026 | Isshiki et al. | Apr 2002 | A1 |
20020052547 | Toida | May 2002 | A1 |
20020057431 | Fateley et al. | May 2002 | A1 |
20020064341 | Fauver et al. | May 2002 | A1 |
20020076152 | Hughes et al. | Jun 2002 | A1 |
20020085209 | Mittleman et al. | Jul 2002 | A1 |
20020086347 | Johnson et al. | Jul 2002 | A1 |
20020091322 | Chaiken et al. | Jul 2002 | A1 |
20020093662 | Chen et al. | Jul 2002 | A1 |
20020109851 | Deck | Aug 2002 | A1 |
20020122182 | Everett et al. | Sep 2002 | A1 |
20020122246 | Tearney et al. | Sep 2002 | A1 |
20020140942 | Fee et al. | Oct 2002 | A1 |
20020158211 | Gillispie | Oct 2002 | A1 |
20020161357 | Anderson et al. | Oct 2002 | A1 |
20020163622 | Magnin et al. | Nov 2002 | A1 |
20020168158 | Furusawa et al. | Nov 2002 | A1 |
20020172485 | Keaton et al. | Nov 2002 | A1 |
20020183623 | Tang et al. | Dec 2002 | A1 |
20020188204 | McNamara et al. | Dec 2002 | A1 |
20020196446 | Roth et al. | Dec 2002 | A1 |
20020198457 | Tearney et al. | Dec 2002 | A1 |
20030001071 | Mandella et al. | Jan 2003 | A1 |
20030013973 | Georgakoudi et al. | Jan 2003 | A1 |
20030023153 | Izatt et al. | Jan 2003 | A1 |
20030026735 | Nolte et al. | Feb 2003 | A1 |
20030028114 | Casscells, III et al. | Feb 2003 | A1 |
20030030816 | Eom et al. | Feb 2003 | A1 |
20030043381 | Fercher | Mar 2003 | A1 |
20030053673 | Dewaele et al. | Mar 2003 | A1 |
20030067607 | Wolleschensky et al. | Apr 2003 | A1 |
20030082105 | Fischman et al. | May 2003 | A1 |
20030097048 | Ryan et al. | May 2003 | A1 |
20030108911 | Klimant et al. | Jun 2003 | A1 |
20030120137 | Pawluczyk et al. | Jun 2003 | A1 |
20030135101 | Webler | Jul 2003 | A1 |
20030137669 | Rollins et al. | Jul 2003 | A1 |
20030164952 | Deichmann et al. | Sep 2003 | A1 |
20030165263 | Hamer et al. | Sep 2003 | A1 |
20030171691 | Casscells, III et al. | Sep 2003 | A1 |
20030174339 | Feldchtein et al. | Sep 2003 | A1 |
20030199769 | Podoleanu et al. | Oct 2003 | A1 |
20030216719 | Debenedictics et al. | Nov 2003 | A1 |
20030220749 | Chen et al. | Nov 2003 | A1 |
20030236443 | Cespedes et al. | Dec 2003 | A1 |
20040002650 | Mandrusov et al. | Jan 2004 | A1 |
20040039298 | Abreu | Feb 2004 | A1 |
20040054268 | Esenaliev et al. | Mar 2004 | A1 |
20040072200 | Rigler et al. | Apr 2004 | A1 |
20040075841 | Van Neste et al. | Apr 2004 | A1 |
20040076940 | Alexander et al. | Apr 2004 | A1 |
20040077949 | Blofgett et al. | Apr 2004 | A1 |
20040085540 | Lapotko et al. | May 2004 | A1 |
20040086245 | Farroni et al. | May 2004 | A1 |
20040100631 | Bashkansky et al. | May 2004 | A1 |
20040100681 | Bjarklev et al. | May 2004 | A1 |
20040110206 | Wong et al. | Jun 2004 | A1 |
20040126048 | Dave et al. | Jul 2004 | A1 |
20040126120 | Cohen et al. | Jul 2004 | A1 |
20040133191 | Momiuchi et al. | Jul 2004 | A1 |
20040150829 | Koch et al. | Aug 2004 | A1 |
20040150830 | Chan | Aug 2004 | A1 |
20040152989 | Puttappa et al. | Aug 2004 | A1 |
20040165184 | Mizuno | Aug 2004 | A1 |
20040166593 | Nolte et al. | Aug 2004 | A1 |
20040189999 | De Groot et al. | Sep 2004 | A1 |
20040212808 | Okawa et al. | Oct 2004 | A1 |
20040239938 | Izatt et al. | Dec 2004 | A1 |
20040246490 | Wang | Dec 2004 | A1 |
20040246583 | Mueller et al. | Dec 2004 | A1 |
20040254474 | Seibel et al. | Dec 2004 | A1 |
20040263843 | Knopp et al. | Dec 2004 | A1 |
20050018133 | Huang et al. | Jan 2005 | A1 |
20050018201 | de Boer et al. | Jan 2005 | A1 |
20050035295 | Bouma et al. | Feb 2005 | A1 |
20050036150 | Izatt et al. | Feb 2005 | A1 |
20050046837 | Izumi et al. | Mar 2005 | A1 |
20050057680 | Agan | Mar 2005 | A1 |
20050057756 | Fang-Yen et al. | Mar 2005 | A1 |
20050059894 | Zeng et al. | Mar 2005 | A1 |
20050065421 | Burckhardt et al. | Mar 2005 | A1 |
20050075547 | Wang | Apr 2005 | A1 |
20050083534 | Riza et al. | Apr 2005 | A1 |
20050119567 | Choi et al. | Jun 2005 | A1 |
20050128488 | Yelin et al. | Jun 2005 | A1 |
20050165303 | Kleen et al. | Jul 2005 | A1 |
20050171438 | Chen et al. | Aug 2005 | A1 |
20050190372 | Dogariu et al. | Sep 2005 | A1 |
20050254061 | Alphonse et al. | Nov 2005 | A1 |
20060033923 | Hirasawa et al. | Feb 2006 | A1 |
20060093276 | Bouma et al. | May 2006 | A1 |
20060103850 | Alphonse et al. | May 2006 | A1 |
20060146339 | Fujita et al. | Jul 2006 | A1 |
20060155193 | Leonardi et al. | Jul 2006 | A1 |
20060164639 | Horn et al. | Jul 2006 | A1 |
20060171503 | O'Hara et al. | Aug 2006 | A1 |
20060184048 | Saadat et al. | Aug 2006 | A1 |
20060193352 | Chong et al. | Aug 2006 | A1 |
20060244973 | Yun et al. | Nov 2006 | A1 |
20070019208 | Toida et al. | Jan 2007 | A1 |
20070038040 | Cense et al. | Feb 2007 | A1 |
20070070496 | Gweon et al. | Mar 2007 | A1 |
20070076217 | Baker et al. | Apr 2007 | A1 |
20070086013 | De Lega et al. | Apr 2007 | A1 |
20070086017 | Buckland et al. | Apr 2007 | A1 |
20070091317 | Freischlad et al. | Apr 2007 | A1 |
20070133002 | Wax et al. | Jun 2007 | A1 |
20070188855 | Shishkov et al. | Aug 2007 | A1 |
20070223006 | Tearney et al. | Sep 2007 | A1 |
20070236700 | Yun et al. | Oct 2007 | A1 |
20070258094 | Izatt et al. | Nov 2007 | A1 |
20070291277 | Everett et al. | Dec 2007 | A1 |
20080002197 | Sun et al. | Jan 2008 | A1 |
20080007734 | Park et al. | Jan 2008 | A1 |
20080049220 | Izzia et al. | Feb 2008 | A1 |
20080094613 | de Boer et al. | Apr 2008 | A1 |
20080094637 | de Boer et al. | Apr 2008 | A1 |
20080097225 | Tearney et al. | Apr 2008 | A1 |
20080097709 | de Boer et al. | Apr 2008 | A1 |
20080100837 | de Boer et al. | May 2008 | A1 |
20080152353 | de Boer et al. | Jun 2008 | A1 |
20080154090 | Hashimshony | Jun 2008 | A1 |
20080204762 | Izatt et al. | Aug 2008 | A1 |
20080265130 | Colomb et al. | Oct 2008 | A1 |
20080308730 | Vizi et al. | Dec 2008 | A1 |
20090011948 | Uniu et al. | Jan 2009 | A1 |
20090196477 | Cense et al. | Aug 2009 | A1 |
20090273777 | Yun et al. | Nov 2009 | A1 |
20090290156 | Popescu et al. | Nov 2009 | A1 |
20100086251 | Xu et al. | Apr 2010 | A1 |
20100094576 | de Boer et al. | Apr 2010 | A1 |
20100150467 | Zhao et al. | Jun 2010 | A1 |
Number | Date | Country |
---|---|---|
1550203 | Dec 2004 | CN |
4105221 | Sep 1991 | DE |
4309056 | Sep 1994 | DE |
19542955 | May 1997 | DE |
10351319 | Jun 2005 | DE |
0110201 | Jun 1984 | EP |
0251062 | Jan 1988 | EP |
0617286 | Feb 1994 | EP |
0590268 | Apr 1994 | EP |
0728440 | Aug 1996 | EP |
0933096 | Aug 1999 | EP |
1324051 | Jul 2003 | EP |
1426799 | Jun 2004 | EP |
2738343 | Aug 1995 | FR |
1257778 | Dec 1971 | GB |
2030313 | Apr 1980 | GB |
2209221 | May 1989 | GB |
2298054 | Aug 1996 | GB |
6073405 | Apr 1985 | JP |
20040056907 | Feb 1992 | JP |
4135550 | May 1992 | JP |
4135551 | May 1992 | JP |
5509417 | Nov 1993 | JP |
2002214127 | Jul 2002 | JP |
20030035659 | Feb 2003 | JP |
2007271761 | Oct 2007 | JP |
7900841 | Oct 1979 | WO |
9201966 | Feb 1992 | WO |
9216865 | Oct 1992 | WO |
9219930 | Nov 1992 | WO |
9303672 | Mar 1993 | WO |
9533971 | Dec 1995 | WO |
9628212 | Sep 1996 | WO |
9732182 | Sep 1997 | WO |
9800057 | Jan 1998 | WO |
9801074 | Jan 1998 | WO |
9814132 | Apr 1998 | WO |
9835203 | Aug 1998 | WO |
9838907 | Sep 1998 | WO |
9846123 | Oct 1998 | WO |
9848838 | Nov 1998 | WO |
9848846 | Nov 1998 | WO |
9905487 | Feb 1999 | WO |
9944089 | Feb 1999 | WO |
9944089 | Sep 1999 | WO |
9957507 | Nov 1999 | WO |
0058766 | Oct 2000 | WO |
0101111 | Jan 2001 | WO |
0108579 | Feb 2001 | WO |
0127679 | Apr 2001 | WO |
0138820 | May 2001 | WO |
0142735 | Jun 2001 | WO |
0236015 | May 2002 | WO |
0237075 | May 2002 | WO |
0238040 | May 2002 | WO |
02053050 | Jul 2002 | WO |
02054027 | Jul 2002 | WO |
02084263 | Oct 2002 | WO |
03020119 | Mar 2003 | WO |
03046495 | Jun 2003 | WO |
03046636 | Jun 2003 | WO |
03052478 | Jun 2003 | WO |
03062802 | Jul 2003 | WO |
03105678 | Dec 2003 | WO |
2004034869 | Apr 2004 | WO |
2004057266 | Jul 2004 | WO |
2004066824 | Aug 2004 | WO |
2004088361 | Oct 2004 | WO |
2004105598 | Dec 2004 | WO |
2005000115 | Jan 2005 | WO |
2005047813 | May 2005 | WO |
2005054780 | Jun 2005 | WO |
2005082225 | Sep 2005 | WO |
2006004743 | Jan 2006 | WO |
2006014392 | Feb 2006 | WO |
2006038876 | Apr 2006 | WO |
2006039091 | Apr 2006 | WO |
2006059109 | Jun 2006 | WO |
2006124860 | Nov 2006 | WO |
2006130797 | Dec 2006 | WO |
2007028531 | Mar 2007 | WO |
2007038787 | Apr 2007 | WO |
2007083138 | Jul 2007 | WO |
2007084995 | Jul 2007 | WO |
Number | Date | Country | |
---|---|---|---|
20070276269 A1 | Nov 2007 | US |
Number | Date | Country | |
---|---|---|---|
60799511 | May 2006 | US |